Drugs Xagena
Novartis has provided a safety update to European regulators of pooled data showing numerically less frequent liver enzyme elevations in patients who took either 50 mg per day or 50 mg twice daily of ...
The FDA ( Food and Drug Administration ) has approved revised boxed warnings and other safety-related product labeling changes for erythropoiesis-stimulating agents ( ESAs ), which treat certain types ...
The FDA ( Food and Drug Administration ) has approved Nexavar ( Sorafenib ) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable. Nexavar ...
The FDA ( Food and Drug Administration ) announced that the manufacturer of Avandia ( Rosiglitazone ), a drug used to treat type 2 diabetes, has agreed to add new information to the existing boxed war ...
Voltaren Gel ( Diclofenac sodium topical gel ) 1% has received FDA approval as the first topical prescription treatment that patients can apply directly to sites of pain associated with osteoarthritis ...
An article in of The Lancet Infectious Diseases has raised the question about increased mortality with the use of Cefepime ( Yahav D, Paul M, Fraser A et al. Efficacy and safety of Cefepime: a systema ...
The FDA ( Food and Drug Administration ) has approved Bystolic ( Nebivolol ), a beta blocker, for the treatment of high blood pressure. The safety and efficacy of Bystolic in lowering blood press ...
The purpose of the study by researchers from American University of Beirut Medical Center, Beirut, Lebanon, was to identify risk factors for subclinical hypothyroidism ( TSH, thyroid-stimulating hormo ...
Zonisamide ( Zonegran ) is a sulphonamide derivative that inhibits carbonic anhydrase; it resembles Topiramate ( Topamax ). The main clinical trial, a double-blind study lasting 36 weeks, compared ...
Bisphosphonates constitute a group of compounds and their structure is based on that of pyrophosphate:a compound that regulated precipitation and extraction of minerals from the bone, albeit they ar ...
Vitamins C and E and Beta-Carotene, either individually or in combination, do not appear to reduce the risk of cardiovascular events or death among women at high risk for heart disease. Oxidative d ...
Zolpidem ( Stilnox ) was marketed in Australia in late 2000 for the short term treatment of insomnia. It is structurally unrelated to the benzodiazepines, but has a similar pharmacological action. ...
The FDA ( Food and Drug Administration ) is aware of a potential safety issue related to Rosiglitazone ( Avandia ). Safety data from a pooled analysis of controlled clinical trials have shown a signi ...
The FDA ( Food and Drug Administration ) is aware of a potential safety issue related to Avandia ( Rosiglitazone ), a drug approved to treat type 2 diabetes. Safety data from controlled clinical tria ...
The FDA ( Food and Drug Administration ) has approved Neupro ( Rotigotine transdermal system ), a skin patch designed to treat symptoms of early Parkinson's disease. Rotigotine is a drug not previ ...
The FDA ( Food and Drug Administration ) proposed that makers of all antidepressant medications update the existing black box warning on their products' labeling to include warnings about increased ri ...
The EMEAs Committee for Medicinal Products for Human Use ( CHMP ) reminds healthcare professionals that Baraclude ( Entecavir ) has not been evaluated for the treatment of patients with chronic hepat ...
Eli Lilly announced that the European Medicines Agency ( EMEA ) has granted Enzastaurin, an investigational, multi-targeted, oral, cancer agent, orphan drug designation for the treatment of diffuse la ...
The FDA ( Food and Drug Administration ) announced that manufacturers of Pergolide drug products, which are used to treat Parkinsons disease, will voluntarily remove these drugs from the market becau ...
The FDA ( Food and Drug Administration ) has requested that all manufacturers of sedative-hypnotic drug products, a class of drugs used to induce and/or maintain sleep, strengthen their product labeli ...
The FDA ( Food and Drug Administration ) has approved Tykerb ( Lapatinib ), a new targeted anti-cancer treatment, to be used in combination with Capectabine ( Xeloda ), another cancer drug, for patien ...
Tumour necrosis factor alpha ( TNF-alpha ) is a cellular protein produced by the immune system and is an important mediator of many diseases, including inflammatory arthritis and inflammatory bowel di ...
Gallstones and alcohol are the two most common causes of pancreatitis, but medicines are estimated to account for about 2 to 5% of cases. ADRAC ( Adverse Drug Reactions Advisory Committee ) has recei ...
Leflunomide ( Arava ) is a disease-modifying anti-rheumatic drug ( DMARD ) for the treatment of rheumatoid arthritis, which has been available in Australia since 2000. A publication described 7 Aust ...
The FDA ( Food and Drug Administration ) announced the approval of Tekturna ( Aliskiren ) tablets for the treatment of hypertension, which causes increased risk of stroke, myocardial infarction, kidne ...
The FDA ( Food and Drug Administration ) has approved Humira ( Adalimumab ) to treat adult patients with moderately to severely active Crohn's disease, a chronic inflammatory disease of the intestines ...
Roche Laboratories, following discussion with the FDA ( Food and Drug Administration ), informed Health Care Professionals of important safety information regarding the termination of the Heart Spare ...
The FDA ( Food and Drug Administration ) directed the manufacturers of all drug products approved for the treatment of Attention Deficit Hyperactivity Disorder ( ADHD ) to develop Patient Medication G ...
Levofloxacin ( Levaquin ) is a broad-spectrum fluoroquinolone antibiotic that is indicated for the treatment of certain respiratory tract, skin and urinary tract bacterial infections in adults. Dysgly ...
The FDA ( Food and Drug Administration ) announced the approval of antihemophilic factor / von Willebrand factor complex ( human ), Alphanate. The product is approved for patients undergoing surgery ...
The FDA ( Food and Drug Administration ) announced revisions to the labeling for the antibiotic Ketek ( Telithromycin ) designed to improve the safe use of Ketek by patients. The changes include the r ...
Roche announced that the European Commission has approved Mircera to treat anemia associated with chronic kidney disease. The Commissions decision follows a Positive Opinion by the Committee for Me ...
Researches at Elkhart General Hospital, in United States, have assessed the prevalence of osteonecrosis of the jaw in patients receiving bisphosphonate therapy and in those who were bisphosphonate naï ...
ADRAC ( Adverse Drug Reactions Advisory Committee ) has previously noted that the two oldest of the atypical antipsychotics, Clozapine ( Clozaril ) and Olanzapine ( Zyprexa ), can cause neuroleptic m ...
The thiazolidinedione Rosiglitazone ( Avandia ) is an insulin sensitizer that is indicated for use either as monotherapy or in combination with Metformin or a sulfonylurea in patients whose type 2 dia ...
Novartis has informed HealthCare Provider about the December 2006 changes made to the WARNINGS and ADVERSE REACTIONS sections of the Exjade ( Deferasirox ) tablets for oral suspension prescribing info ...
The FDA ( Food and Drug Administration ) has approved Letairis ( Ambrisentan ) for the treatment of pulmonary arterial hypertension, a rare, life-threatening condition characterized by continuous high ...
Rosiglitazone ( Avandia ) is widely used to treat patients with type 2 diabetes mellitus, but its effect on cardiovascular morbidity and mortality has not been determined. Steven E Nissen and Kathy W ...
Genentech and FDA ( Food and Drug Administration ) informed HealthCare Providers of important new safety information regarding Avastain ( Bevacizumab ). Tracheoesophageal fistula has been seen in ...
Acorda Therapeutics anf FDA ( Food and Drug Administration ) have informed that concomitant use of Tizanidine ( Zanaflex ) with Fluvoxamine ( Luvox ) or Ciprofloxacin ( Cipro ), potent CYP1A2 inhibito ...
The FDA ( Food and Drug Administration ) has approved Altabax ( Retapamulin ointment ) for topical treatment of impetigo due to susceptible strains of Staphylococcus aureus or Streptococcus pyogenes, ...
The FDA ( Food and Drug Administration ) has informed patients and health care professionals that the sponsor of Zelnorm ( Tegaserod ), Novartis Pharmaceuticals, has agreed to stop selling Zelnorm. ...
GlaxoSmithKline ( GSK ) has informed HealthCare Professionals of recent safety data concerning Rosiglitazone-containing products, i.e., Avandia ( Rosiglitazone maleate ) tablets, Avandamet ( Rosiglita ...
A study has assessed the effectiveness of Phenylephrine, the active ingredient in products such as Actifed, Sudafed PE, and Tylenol Sinus. The meta-analysis of 15 previous studies concludes that ...
A study published in the the New England Journal of Medicine ( NEJM ) suggests that repeated topical use of products containing lavender oil and/or tea tree oil may cause prepubertal gynecomastia, a r ...
Gastrointestinal graft-versus-host disease is a common and potentially deadly side effect for patients who undergo an allogeneic stem-cell transplant to treat certain blood cancers. A research from F ...
Narcotic drugs ( opioids ) are commonly prescribed for short-term relief of chronic back pain, but their effectiveness long-term has been questioned in a review article by researchers at Yale School o ...
Benzodiazepine use was not shown to be associated with hip fractures after all, according to a new study from Harvard Medical School and Harvard Pilgrim Health Care. Previous epidemiological studies ...
Takeda Pharmaceuticals, in according to FDA ( Food and Drug Administration ) has informed healthcare providers about recent safety data concerning Pioglitazone-containing products, i.e., Actos, ActoPl ...
A research suggests that the pharmacological effects of taking medications such as statins and beta-blockers as prescribed following a heart attack is associated with living longer. Clinical trials ...
